Dong Wei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in
-
- Bacillus and Francisella bacterial research 4
- Circular RNAs in diseases 4
- DNA Repair Mechanisms 3
- Natural product bioactivities and synthesis 3
- Ubiquitin and proteasome pathways 3
- Peroxisome Proliferator-Activated Receptors 3
-
- MicroRNA in disease regulation 3
- Co-authors
- Shengming DaiXiangyang ZhouZhen WuXiaomou WeiHaixin HuangGuisheng LiYubing SunVincent Maher
- Journals
- European Journal of Medicinal Chemistry (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Cellular and Molecular Medicine (2 papers)PLoS ONE (2 papers)The Prostate (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Dong Wei
33 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 518
- Molecular Biology 1.1k
- Immunology 207
- Oncology 140
- Biotechnology 34
Countries citing papers authored by Dong Wei
This map shows the geographic impact of Dong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Wei more than expected).
Fields of papers citing papers by Dong Wei
This network shows the impact of papers produced by Dong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Wei. The network helps show where Dong Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 36 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 58 | |
| 10 | 2017 | 10 | |
| 11 | 2017 | 38 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 11 | |
| 14 | Determination of concentration of anthrax vaccine by spectrophotometry. | 2010 | 1 |
| 15 | 2010 | 76 | |
| 16 | 2009 | 16 | |
| 17 | Study of Health Protection on Antioxidation and Reducing Blood Lipid of Arctium lappa L. | 2008 | 4 |
| 18 | 2008 | 7 | |
| 19 | Study on Anti-fatigue Function of the Extracts from Arctium lappa L | 2006 | 1 |
| 20 | A NEW COMPOUND FROM ACALYPHA AUSTRALIS | 1994 | 2 |
About Dong Wei
Dong Wei is a scholar working on Molecular Biology, Cancer Research, Biochemistry, Toxicology and Oncology, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Bacillus and Francisella bacterial research (4 papers), Circular RNAs in diseases (4 papers), DNA Repair Mechanisms (3 papers), MicroRNA in disease regulation (3 papers), Natural product bioactivities and synthesis (3 papers), Ubiquitin and proteasome pathways (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Cancer Research (518 citations), Molecular Biology (1.1k citations), Immunology (207 citations), Oncology (140 citations) and Biotechnology (34 citations). Dong Wei has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Shengming Dai, Xiangyang Zhou, Zhen Wu, Xiaomou Wei, Haixin Huang, Guisheng Li, Yubing Sun, Vincent Maher, J. Justin McCormick and Lina Guo. Their work appears in journals such as European Journal of Medicinal Chemistry, International Journal of Molecular Sciences, Journal of Cellular and Molecular Medicine, PLoS ONE and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.